REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharma Corp. Inc. Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pharma Corp. Inc. Private Limited Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharma Corp. Inc. Private Limited is an unlisted company, incorporated on 24/11/2008. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24230MP2008PTC021361 and registration number is 021361.

Legal Address
Plot No.49, Sk Compound 1 Mr-11, Lasuria Mori, Dewas Naka
Indore; Madhya Pradesh; Postal Code: 452010

Contact Details: Purchase the Pharma Corp. Inc. Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pharma Corp. Inc. Private Limited report to view the information.
Registered Capital:
Purchase the Pharma Corp. Inc. Private Limited report to view the information.
Incorporation Date:
November 24, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
7.5%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Pharma Corp. Inc. Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.31%▲
Total operating revenue
4.5%▲
Operating profit (EBIT)
20.79%▲
EBITDA
15.58%▲
Net Profit (Loss) for the Period
19.83%▲
Total assets
1.9%▲
Total equity
11.72%▲
Operating Profit Margin (ROS)
0.53%▲
Net Profit Margin
0.37%▲
Return on Equity (ROE)
0.71%▲
Debt to Equity Ratio
9.75%▲
Quick Ratio
0.36%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo